• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia

Exclusive

An hour in the Oval Office with President Trump Fortune Editor-in-Chief: Alyson Shontell sat down with President Trump in the Oval Office for an hour. Tariffs, Intel, AI, Boeing, Iran—and the question every CEO eventually has to answer: who's next?

An hour in the Oval Office with President Trump Fortune Editor-in-Chief: Alyson Shontell sat down with President Trump in the Oval Office for an hour. Tariffs, Intel, AI, Boeing, Iran—and the question every CEO eventually has to answer: who's next?

An hour in the Oval Office with President Trump Fortune Editor-in-Chief: Alyson Shontell sat down with President Trump in the Oval Office for an hour. Tariffs, Intel, AI, Boeing, Iran—and the question every CEO eventually has to answer: who's next?

An hour in the Oval Office with President Trump Fortune Editor-in-Chief: Alyson Shontell sat down with President Trump in the Oval Office for an hour. Tariffs, Intel, AI, Boeing, Iran—and the question every CEO eventually has to answer: who's next?

An hour in the Oval Office with President Trump Fortune Editor-in-Chief: Alyson Shontell sat down with President Trump in the Oval Office for an hour. Tariffs, Intel, AI, Boeing, Iran—and the question every CEO eventually has to answer: who's next?

An hour in the Oval Office with President Trump Fortune Editor-in-Chief: Alyson Shontell sat down with President Trump in the Oval Office for an hour. Tariffs, Intel, AI, Boeing, Iran—and the question every CEO eventually has to answer: who's next?

An hour in the Oval Office with President Trump Fortune Editor-in-Chief: Alyson Shontell sat down with President Trump in the Oval Office for an hour. Tariffs, Intel, AI, Boeing, Iran—and the question every CEO eventually has to answer: who's next?

An hour in the Oval Office with President Trump Fortune Editor-in-Chief: Alyson Shontell sat down with President Trump in the Oval Office for an hour. Tariffs, Intel, AI, Boeing, Iran—and the question every CEO eventually has to answer: who's next?

An hour in the Oval Office with President Trump Fortune Editor-in-Chief: Alyson Shontell sat down with President Trump in the Oval Office for an hour. Tariffs, Intel, AI, Boeing, Iran—and the question every CEO eventually has to answer: who's next?

An hour in the Oval Office with President Trump Fortune Editor-in-Chief: Alyson Shontell sat down with President Trump in the Oval Office for an hour. Tariffs, Intel, AI, Boeing, Iran—and the question every CEO eventually has to answer: who's next?

CommentaryRoe v. Wade

With Roe v. Wade out, we need male contraception more than ever

By
Akash Bakshi
Akash Bakshi
Down Arrow Button Icon
By
Akash Bakshi
Akash Bakshi
Down Arrow Button Icon
July 29, 2022, 6:15 AM ET
Hormonal contraceptive methods for women come with side effects such as mood changes, depression, an increased risk of breast and cervical cancer, and blood clots. But when it comes to men, it is widely assumed side effects would be unacceptable.
Hormonal contraceptive methods for women come with side effects such as mood changes, depression, an increased risk of breast and cervical cancer, and blood clots. But when it comes to men, it is widely assumed side effects would be unacceptable.Getty Images

Roe v. Wade has been overturned, resulting in reduced access to safe and effective abortions. It’s a devastating moment for the health and well-being of American women and individuals who can become pregnant.

We should consider why women need abortions in the first place. For many (but not all–some women require abortions for medical reasons), it’s unintended pregnancy. For every two pregnant women in America, one of their pregnancies is unintended. About 40% of those women choose to have an abortion, which is now outlawed in as many as 28 states in America. 

But unplanned isn’t a synonym for unprotected. As many as 50% of couples observed in a study by the Guttmacher Institute were actively using a contraceptive when they became pregnant. It won’t be a surprise to learn that condoms are behind many well-intentioned yet failed efforts to prevent pregnancy. The pill, too, can fail: 12% of women who seek an abortion were on the pill. 

Of course, the protections previously granted by Roe must be codified into law. But we also need better contraceptives. We always have. We need to empower people to prevent unwanted pregnancy and the need for abortion. We can also increase access to highly effective contraceptives and bring men into the conversation. After all, women don’t get pregnant alone.  

Efficacy aside, nearly every woman who is on a hormonal contraceptive weighs side effects that include mood changes, depression, an increased risk of breast and cervical cancer, and blood clots.

Male birth control doesn’t exist today beyond the technologies developed in the 1800s: condoms, which come with high failure rates, or vasectomies, which aren’t yet reliably reversible. But if it did, we could decrease unintended pregnancies and, in today’s America, unsafe abortions. 

We need men to claim their full equal responsibility for reproductive health–and it’s not an unrealistic notion. Nearly 75% of women and about 72% of men believe both sexual partners should be equally responsible for birth control. There is a massive untapped market for novel male contraceptives that are highly effective, reversible, and convenient to use. There is also a glaring gap in interest, research, and funding in the field of male reproduction. Biologically, it’s challenging: successful contraception requires us to stop millions of sperm from reaching an egg, and it’s difficult to target human sperm cells.

To suggest that men aren’t looking beyond the condom simply doesn’t reflect the current mood: A recent survey showed that 17 million American men are seeking better contraceptive methods for themselves. 

This wasn’t always the case, of course: It’s widely believed that demand for male contraceptive methods didn’t exist until after paternity tests were developed, putting men on the hook for raising their own offspring.

Regardless, it’s a whole new era for heterosexual women and their relationship with male partners. The #MeToo movement and the 2017 Women’s March on Washington come to mind as flashpoints for modern feminism which aim to hold the country’s most powerful men to account and include a focus on sexual empowerment centered on women’s pleasure. 

Still, many assumed men would be turned off by the possibility of side effects, which suggests a gross double standard in which side effects are acceptable for women but unacceptable for men–a notion that also does not align with the values that younger generations are striving for. 

Let’s empower men to step up during a moment when women’s access to safe and effective abortions is now in grave danger. 

An affordable, reversible contraceptive for men is possible. Private companies are commercializing therapeutics and devices that non-hormonally bring sperm counts below fertile limits in men, essentially offering the benefits of a highly effective contraceptive to men. Other institutions are trialing hormonal methods with tentatively promising efficacy. 

These developments give me hope that someday we can decrease the hormonal burden we put on women in the name of preventing pregnancy. It’s a burden that has compelled so many women to share their stories with me about the effects of birth control on their lives. It’s personal and real. The development of male contraceptives covered by insurance and widely adopted by men can radically change that.

Attacks on reproductive autonomy and a lack of male birth control have put women in devastating positions. But if we’re to decrease the need for abortion, we’ll need men to take on a fair share of responsibility in preventing unwanted pregnancies–and a whole lot of research, funding, and awareness to get us there.

Akash Bakshi is the CEO and co-founder of YourChoice Therapeutics, a company that is developing a birth control pill for men. Akash holds degrees in Biochemistry and Cell Biology from UC San Diego and University of Queensland.

The opinions expressed in Fortune.com commentary pieces are solely the views of their authors and do not reflect the opinions and beliefs of Fortune.

More must-read commentary published by Fortune:

  • COVID got me. Will it come for you?
  • Why remote work will win this fall
  • A list of companies supporting abortion rights after the Roe v. Wade ruling shows which firms are stepping up, and why
  • Career hoarding is on the rise—but it comes at a cost
  • Venture capital is hard–and it’s supposed to be

Sign up for the Fortune Features email list so you don’t miss our biggest features, exclusive interviews, and investigations.

About the Author
By Akash Bakshi
See full bioRight Arrow Button Icon

Latest in Commentary

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025

Most Popular

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

Latest in Commentary

altman
CommentarySam Altman
Musk vs. Altman: AI safety cannot be one man’s job
By Stavros GadinisMay 18, 2026
4 hours ago
charlie
CommentarySoftware
Anaplan CEO: AI isn’t eating software. It’s sorting it
By Charlie GottdienerMay 18, 2026
14 hours ago
shyam
CommentaryHealth
World Economic Forum: women’s health gets only 20% of R&D funding. We must seize this $1 trillion opportunity
By Shyam BishenMay 18, 2026
21 hours ago
murdochs
CommentaryMedia
OpenAI paid $100 million for a talk show. James Murdoch is eyeing an even bigger deal. The hot new asset class is humanity
By Lin CherryMay 17, 2026
2 days ago
dennis
CommentaryAI agents
Freshworks CEO: why agile enterprises are winning the AI race — and what they did differently
By Dennis WoodsideMay 17, 2026
2 days ago
Mary Moreland-Abbott Executive Vice President of Human Resources.
CommentaryRetirement
Gen X is the most indebted generation in America. Their employers can fix that
By Mary MorelandMay 17, 2026
2 days ago

Most Popular

The Bezos family just donated $100 million to help achieve one of Mayor Zohran Mamdani’s top campaign promises
Politics
The Bezos family just donated $100 million to help achieve one of Mayor Zohran Mamdani’s top campaign promises
By Jake AngeloMay 12, 2026
6 days ago
Microsoft AI chief gives it 18 months—for all white-collar work to be automated by AI
AI
Microsoft AI chief gives it 18 months—for all white-collar work to be automated by AI
By Jake AngeloMay 16, 2026
3 days ago
The top foreign holders of U.S. debt may soon dump Treasury bonds and bring their money back home, potentially spiking borrowing costs
Economy
The top foreign holders of U.S. debt may soon dump Treasury bonds and bring their money back home, potentially spiking borrowing costs
By Jason MaMay 17, 2026
1 day ago
SpaceX heads into a record-shattering IPO with the 'deepest moat that exists today' as investors vow to 'never bet against Elon'
Innovation
SpaceX heads into a record-shattering IPO with the 'deepest moat that exists today' as investors vow to 'never bet against Elon'
By Jason MaMay 16, 2026
2 days ago
Mamdani's New York is coming to tax your private jet. Here's how to prepare
Personal Finance
Mamdani's New York is coming to tax your private jet. Here's how to prepare
By Greg RaiffMay 16, 2026
3 days ago
While Trump insisted the Iran war would end ‘soon,’ an account in his name was buying millions in oil, defense and gold
Economy
While Trump insisted the Iran war would end ‘soon,’ an account in his name was buying millions in oil, defense and gold
By Eva RoytburgMay 18, 2026
7 hours ago

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.